Recent News

By Region: North America

Highly pathogenic bird flu confirmed in Arkansas turkeys: USDA

The U.S. Department of Agriculture on Wednesday confirmed the discovery of highly pathogenic avian influenza in a commercial turkey flock in Arkansas, the third-largest U.S. turkey producer and home to Tyson Foods Inc, the nation’s biggest chicken company.

March 19, 2015
| Filed under North America and Public Health
Share

In Pictures: Air National Guard CBRN Training

More than 100 emergency management technicians of the Air National Guard gathered at the Guardian Centers of Georgia in Perry, Ga., in support of the Global Dragon deployment for training exercise on March 9, 2015. Airmen traveled from 20 states, representing more than 20 units and all 10 Federal Emergency Management Agencies.

March 16, 2015
| Filed under North America and Countermeasures
Share

J&J Announce Start of Phase 1 Clinical Trial of Ebola Vaccine

Johnson & Johnson this week announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies. The trial is being led by the Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics. Recruitment in the trial is underway, and the first Read More »

January 12, 2015
| Filed under North America, Biotechnology, and Public Health
Share

UC Davis Working to Help Speed Ebola Drug Production

Researchers at the University of California, Davis will explore ways to speed production of the Ebola drug with a $200,000 rapid-response grant from the National Science Foundation. Developed by Mapp Biopharmaceutical Inc. of San Diego, in collaboration with the U.S. government and partners in Canada, Zmapp is a cocktail of antibodies produced in and extracted Read More »

January 12, 2015
| Filed under Africa, International, North America, Biotechnology, Public Health, and Research
Share

NIAID/GSK Experimental Ebola Vaccine Appears Safe

Results from a National Institutes of Health (NIH) Phase 1 clinical trial support accelerated development of the candidate vaccine to prevent Ebola virus disease.